November 10, 2022
Thursday November 10, 2022 – 4:15 pm – Auditoire E
Mathilde BAUSART - Advanced Drug Delivery and Biomaterials (ADDB) Research Group
Combination of immunotherapy and local chemotherapy for the treatment of unresectable glioblastoma
Promotor: Véronique Préat
Co-promotor: Alessio Malfanti
Related publications:
- Bausart M, Vanvarenberg K, Ucakar B, Lopes A, Vandermeulen G, Malfanti A, Préat V. Combination of DNA vaccine and immune checkpoint blockades improves the immune response in an orthotopic unresectable glioblastoma model. Pharmaceutics 2022;14:1025.
- Bausart M, Préat V, Malfanti A. Immunotherapy for glioblastoma: the promise of combination strategies. J. Exp. Clin. Cancer Res. 2022;41:35.
- Lopes A*, Bastiancich C*, Bausart M, Ligot S, Lambricht L, Vanvarenberg K, Ucakar B, Gallez B, Préat V, Vandermeulen G. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models. J. Immunother. Cancer 2021;9:e001243.
Info: veronique.preat@uclouvain.be
